| Literature DB >> 28138313 |
Han Yan1, Baoxin Liu2, Guilin Meng1, Bo Shang1, Qiqiang Jie2, Yidong Wei2, Xueyuan Liu1.
Abstract
Objective: Socioeconomic status (SES) is being recognized as an important factor in both social and medical problems. The aim of present study is to examine the relationship between SES and ischemic stroke and investigate whether SES is a predictor of clinical outcomes among patients with different neighborhood status from Shanghai, China.Entities:
Keywords: China; Health inequality; Ischemic stroke; Neighborhood status; Socioeconomic status; Survival.
Mesh:
Year: 2017 PMID: 28138313 PMCID: PMC5278663 DOI: 10.7150/ijms.17241
Source DB: PubMed Journal: Int J Med Sci ISSN: 1449-1907 Impact factor: 3.738
Figure 1Distribution of individual SES scores among the enrolled 471 study population. SES, socioeconomic status.
Baseline characteristics according to the tertiles of individual socioeconomic status
| Individual socioeconomic status tertiles | ||||
|---|---|---|---|---|
| Variables | Low (n=153) | Middle (n=161) | High (n=157) | P value |
| 66.7±10.1 | 65.6±11.7 | 65.3±8.6 | 0.420 | |
| 0.335 | ||||
| Men (n, %) | 80 (52.3%) | 76 (47.2%) | 87 (55.4%) | |
| Women (n, %) | 73 (47.7%) | 85 (52.8%) | 70 (44.6%) | |
| CHD (n, %) | 73 (47.7%) | 81 (50.3%) | 82 (52.2%) | 0.727 |
| Hypertension (n, %) | 121 (79.1%) | 119 (73.9%) | 117 (74.5%) | 0.509 |
| Diabetes (n, %) | 66 (43.1 %) | 60 (37.3%) | 60 (38.2 %) | 0.524 |
| Lipid disorders (n, %) | 98 (64.1%) | 101 (62.7 %) | 108 (68.8 %) | 0.494 |
| Smoking (n, %) | 54 (35.3 %) | 64 (39.8%) | 64 (40.8 %) | 0.575 |
| Antiplatelet drugs (n, %) | 106 (69.3 %) | 101 (62.7 %) | 112 (71.3 %) | 0.230 |
| Statins (n, %) | 76 (49.7%) | 88 (54.7 %) | 87 (55.4 %) | 0.546 |
| ACEI/ARB (n, %) | 78 (51.0%) | 83 (51.6 %) | 82 (52.2%) | 0.976 |
| CCB (n, %) | 65 (42.5 %) | 51 (31.7%) | 54 (34.4%) | 0.118 |
| β-blocker (n, %) | 61 (39.9 %) | 68 (42.2 %) | 50 (31.8 %) | 0.137 |
| Diuretics (n, %) | 46 (30.1 %) | 53(32.9 %) | 51 (32.5 %) | 0.844 |
| 5.9±5.2 | 5.6±5.0 | 5.1±5.3 | 0.109 | |
| < 0.001 | ||||
| Low | 17 (11.1%) | 0 | 0 | |
| Medium-Low | 47 (30.7%) | 7 (4.3%) | 3 (1.9%) | |
| Medium | 42 (27.5%) | 20 (12.4%) | 10 (6.4%) | |
| Medium-High | 40 (26.1%) | 73 (45.3%) | 58 (36.9%) | |
| High | 7 (4.6%) | 61 (37.9%) | 86 (54.8%) | |
| < 0.001 | ||||
| Low | 21 (13.7%) | 3 (1.9) | 0 | |
| Medium-Low | 73 (47.7%) | 47 (29.2%) | 11 (7.0%) | |
| Medium | 53 (34.6%) | 95 (59.0%) | 53 (33.8%) | |
| Medium-High | 6 (3.9%) | 16 (9.9%) | 64 (40.8%) | |
| High | 0 | 0 | 29 (18.5%) | |
| < 0.001 | ||||
| Low | 16 (10.5%) | 12 (7.5%) | 2 (1.3%) | |
| Medium-Low | 61 (39.9%) | 33 (20.5%) | 10 (6.4%) | |
| Medium | 56 (36.3%) | 80 (49.7%) | 44 (28.0%) | |
| Medium-High | 20 (13.1%) | 35 (21.7%) | 53 (33.8%) | |
| High | 0 | 1 (0.6%) | 48 (30.6%) | |
| < 0.001 | ||||
| Low | 32 (20.9%) | 10 (6.2%) | 3 (1.9%) | |
| Medium-Low | 58 (37.9%) | 58 (36.0%) | 23 (14.6%) | |
| Medium | 48 (31.4%) | 70 (43.5%) | 58 (36.9%) | |
| Medium-High | 14 (9.2%) | 22 (13.7%) | 60 (38.2%) | |
| High | 1 (0.7%) | 1 (0.6%) | 13 (8.3%) | |
CHD, coronary heart disease; ACEI, angiotensin converting enzyme inhibitors; ARB, angiotensin II receptor blockers; CCB, calcium channel blockers.
The neighborhood status of the enrolled patients according to the tertiles of individual socioeconomic status
| Individual SES tertiles | P value | |||
|---|---|---|---|---|
| Low (n=153) | Middle (n=161) | High (n=157) | ||
| < 0.001 | ||||
| Low (n=137) | #*89 (58.2%) | #Δ25 (15.5%) | *Δ23 (14.6%) | # < 0.001 |
| Middle (n=191) | #*43 (28.1%) | #Δ78 (48.4%) | *Δ70 (44.6%) | # < 0.001 |
| High (n=143) | #*21 (13.7%) | #Δ58 (36.0%) | *Δ64 (40.8%) | # < 0.001 |
SES, socioeconomic status
# Low SES tertile vs. middle SES tertile; * low SES tertile vs. high SES tertile; Δ middle SES tertile vs. high SES tertile
The incidence of clinical adverse event of the study population.
| Clinical adverse events | Individual socioeconomic status tertiles | P value | ||
|---|---|---|---|---|
| Low (n=153) | Middle (n=161) | High (n=157) | ||
| Total (n, %) | #*60 (39.2%) | #Δ47 (29.1%) | *Δ32 (20.3%) | # < 0.001 |
| Death (n, %) | #*20 (13.1%) | #Δ11 (6.8%) | *Δ8 (5.1%) | # 0.001 |
| Nonfatal recurrence (n, %) | 16 (10.5%) | 14 (8.8%) | 11 (7.0%) | 0.560 |
| Post-stroke disability (n, %) | 14 (9.2%) | 13 (8.1%) | 9 (5.8%) | 0.510 |
| Nonfatal recurrence + Post-stroke disability (n, %) | 10 (6.5%) | 9 (5.6%) | 4 (2.5%) | 0.233 |
# Low SES tertile vs. middle SES tertile; * low SES tertile vs. high SES tertile; Δ middle SES tertile vs. high SES tertile.
Figure 2Multivariable adjusted survival curves for clinical adverse events according to individual SES tertiles. (A) Adjusted for age, gender and cardiovascular risk factors. (B) Adjusted for age, gender, cardiovascular risks, education, income, occupation, medical insurance reimbursement and neighborhood status. Cardiovascular risk factors include CHD, hypertension, diabetes mellitus, lipid disorders and smoking. SES, socioeconomic status; CHD, coronary heart disease.
Figure 3Multivariable adjusted survival curves for all-cause mortality according to individual SES tertiles. (A) Adjusted for age, gender and cardiovascular risk factors. (B) Adjusted for age, gender, cardiovascular risks, education, income, occupation, medical insurance reimbursement and neighborhood status. Cardiovascular risk factors include CHD, hypertension, diabetes mellitus, lipid disorders and smoking. SES, socioeconomic status; CHD, coronary heart disease.
Adjusted HRs for combined influences of individual and neighborhood SES on clinical outcomes of ischemic stroke patients
| Clinical adverse events | Mortality | |||
|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | |
| 0.988 (0.973-1.004) | 0.132 | 0.976 (0.959-0.996) | 0.019 | |
| 0.203 (0.882-1.640) | 0.242 | 1.228 (0.825-1.828) | 0.311 | |
| 1.023 (0.751-1.394) | 0.887 | 1.101 (0.740-1.638) | 0.636 | |
| 0.873 (0.598-1.274) | 0.481 | 0.718 (0.427-1.207) | 0.212 | |
| 0.821 (0.596-1.131) | 0.228 | 0.736 (0.489-1.107) | 0.141 | |
| 1.041 (0.753-1.439) | 0.809 | 0.960 (0.632-1.459) | 0.849 | |
| 1.052 (0.759-1.458) | 0.762 | 1.073 (0.704-1.635) | 0.743 | |
| 0.767 (0.623-0.944) | 0.012 | 0.677 (0.515-0.890) | 0.005 | |
| 0.730 (0.582-0.916) | 0.007 | 0.557 (0.410-0.757) | < 0.001 | |
Values are presented as HRs (95% CI). HRs and 95% CIs were estimated with multivariate Cox regression analysis.
HR, hazard ratio; CHD, coronary heart disease; SES, socioeconomic status; CI, confidence interval.
Figure 4Adjusted HRs for clinical adverse events and all-cause mortality of ischemic stroke patients. (A) Multivariate Cox regression analysis demonstrated both individual SES and neighborhood status are independent correlated of clinical adverse events. (B) Multivariate Cox regression analysis revealed that age, individual SES and neighborhood status are all important predictors for all-cause mortality in ischemic stroke. HR, hazard ratio; SES, socioeconomic status; CHD, coronary heart disease.
Adjusted HRs for clinical outcomes in ischemic stroke patients according to individual SES and neighborhood status
| Variables | Clinical adverse events | All-cause mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| Model 1* | Model 2# | Model 1* | Model 2# | |||||
| HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |
| 2.127 (1.427-3.171) | < 0.001 | 1.736 (1.129-2.668) | 0.012 | 3.057 (1.817-5.143) | < 0.001 | 2.127 (1.220-3.710) | 0.008 | |
| 1.512 (1.003-2.281) | 0.048 | 1.495 (0.991-2.255) | 0.056 | 1.421 (0.801-2.520) | 0.229 | 1.414 (0.797-2.509) | 0.236 | |
| Reference | Reference | Reference | Reference | |||||
| 2.326 (1.504-3.596) | < 0.001 | 1.954 (1.222-3.126) | 0.005 | 4.085 (2.236-7.363) | < 0.001 | 3.053 (1.619-5.760) | 0.001 | |
| 1.500 (0.978-2.302) | 0.063 | 1.450 (0.946-2.223) | 0.089 | 1.645 (0.886-3.054) | 0.115 | 1.567 (0.845-2.908) | 0.154 | |
| Reference | Reference | Reference | Reference | |||||
Values are presented as HRs (95% CI). HRs and 95% CIs were estimated with multivariate Cox regression analysis.
HR, hazard ratio; SES, socioeconomic status; CI, confidence interval.
*Adjusted for age, gender, cardiovascular risks. #Adjusted for age, gender, cardiovascular risks, individual SES, neighborhood SES. Cardiovascular risk factors include CHD, hypertension, diabetes mellitus, lipid disorders and smoking.
Adjusted HRs for clinical outcomes according to neighborhood status among individual SES in ischemic stroke patients
| Individual SES | Neighborhood status | Clinical adverse events | All-cause mortality | ||
|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | ||
| 1.550 (0.593-4.051) | 0.372 | 3.570 (0.925-13.782) | 0.065 | ||
| 1.506 (0.605-3.749) | 0.379 | 2.339 (0.606-9.031) | 0.218 | ||
| Reference | Reference | ||||
| 2.237 (0.775-6.451) | 0.137 | 1.818 (0.394-8.403) | 0.444 | ||
| 1.786 (0.560-5.682) | 0.327 | 1.091 (0.215-5.541) | 0.917 | ||
| Reference | Reference | ||||
| 4.477 (0.858-23.366) | 0.075 | 5.280 (0.539-51.734) | 0.153 | ||
| 1.987 (0.564-6.995) | 0.285 | 1.298 (0.203-8.301) | 0.783 | ||
| Reference | Reference | ||||
Values are presented as HRs (95% CI). HRs and 95% CIs were estimated with multivariate Cox regression analysis adjusted for age, gender, cardiovascular risk factors, education, household income, occupation, medical insurance reimbursement and neighborhood status.
HR, hazard ratio; SES, socioeconomic status; CI, confidence interval.
Adjusted HRs for clinical outcomes according to individual SES among neighborhood status in ischemic stroke patients
| Neighborhood status | Individual SES | Clinical adverse events | All-cause mortality | ||
|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | ||
| 1.912 (1.100-3.322) | 0.022 | 2.074 (1.103-3.906) | 0.024 | ||
| 1.031 (1.012-1.075) | 0.044 | 1.038 (1.003-1.075) | 0.033 | ||
| Reference | Reference | ||||
| 2.096 (1.092-4.026) | 0.026 | 2.628 (1.050-6.581) | 0.039 | ||
| 1.315 (0.718-2.409) | 0.376 | 1.609 (0.668-3.873) | 0.289 | ||
| Reference | Reference | ||||
| 1.983 (0.716-5.492) | 0.188 | 1.664 (0.399-6.939) | 0.485 | ||
| 1.457 (0.643-3.304) | 0.367 | 1.024 (0.315-3.289) | 0.969 | ||
| Reference | Reference | ||||
Values are presented as HRs (95% CI). HRs and 95% CIs were estimated with multivariate Cox regression analysis adjusted for age, gender, cardiovascular risk factors, and individual SES.
HR, hazard ratio; SES, socioeconomic status; CI, confidence interval.